ZEPP HEALTH CORP-ADR (ZEPP) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:ZEPP - US98945L2043 - ADR
28.64 USD
-0.37 (-1.28%)
ChartMill assigns a Buy % Consensus number of 85% to ZEPP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 63.07. This target is 120.2% above the current price.
ZEPP was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ZEPP.
In the previous month the buy percentage consensus was at a similar level.
ZEPP was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
ZEPP HEALTH CORP-ADR / ZEPP FAQ
Can you provide the average price target for ZEPP HEALTH CORP-ADR stock?
8 analysts have analysed ZEPP and the average price target is 63.07 USD. This implies a price increase of 120.2% is expected in the next year compared to the current price of 28.64.
How do analysts rate ZEPP HEALTH CORP-ADR (ZEPP)?
The consensus rating for ZEPP HEALTH CORP-ADR (ZEPP) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover ZEPP HEALTH CORP-ADR (ZEPP) stock?
The number of analysts covering ZEPP HEALTH CORP-ADR (ZEPP) is 8.